276702-20-6Relevant articles and documents
Discovery of potent and orally bioavailable N,N′-diarylurea antagonists for the CXCR2 chemokine receptor
Jin, Qi,Nie, Hong,McCleland, Brent W.,Widdowson, Katherine L.,Palovich, Michael R.,Elliott, John D.,Goodman, Richard M.,Burman, Miriam,Sarau, Henry M.,Ward, Keith W.,Nord, Melanie,Orr, Bonnie M.,Gorycki, Peter D.,Busch-Petersen, Jakob
, p. 4375 - 4378 (2007/10/03)
A series of 3-substituted N,N′-diarylureas was prepared and CXCR2 receptor affinities as well as pharmacokinetic properties were examined. A series of 3-substituted N,N′-diarylureas was prepared and the structure-activity relationship relative to CXCR2 re
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
-
Page 88, (2008/06/13)
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
Il-8 receptor antagonists
-
, (2008/06/13)
This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).